Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Idioma
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue ; 16(3): 169-71, 2004 Mar.
Artículo en Zh | MEDLINE | ID: mdl-15009968

RESUMEN

OBJECTIVE: To observe the reperfusion rate of acute myocardial infarction (AMI) affected by inspiring nitric oxide (NO) and resolving thrombus through veins. METHODS: Sixty cases with AMI were randomly divided into test group (n=30) and control groups (n=30). Patients in test group were cured with NO (20+/-1)mg/L inspiration for 30 minutes at once before admission and urokinase (150x10(4) U) adding 0.9% sodium chloride intravenously injected within 30 minutes, while patients in control were treated with urokinase as the same method of the test group. RESULTS: The reperfusion and non-reperfusion patients were 25 and 5 cases in test group, and they were 19 and 11 cases in control group. The reperfusion rate of AMI in test group was significantly higher than that in control group 83.3% vs. 63.3% (P<0.05). No peak periods of lactate dehydrogenase (LDH) and creatine phosphokinase (CPK) appeared in test group, and the difference was significant compared to the control group (P<0.05). CONCLUSION: NO inspiration before urokinase is an effective method to treat AMI and advance the reperfusion rate.


Asunto(s)
Infarto del Miocardio/terapia , Reperfusión Miocárdica , Óxido Nítrico/uso terapéutico , Activador de Plasminógeno de Tipo Uroquinasa/uso terapéutico , Trombosis de la Vena/tratamiento farmacológico , Anciano , Estudios de Casos y Controles , Creatina Quinasa/sangre , Femenino , Depuradores de Radicales Libres/uso terapéutico , Corazón/efectos de los fármacos , Corazón/fisiopatología , Humanos , Inyecciones Intravenosas , L-Lactato Deshidrogenasa/sangre , Masculino , Persona de Mediana Edad , Activadores Plasminogénicos/administración & dosificación , Activadores Plasminogénicos/uso terapéutico , Resultado del Tratamiento , Activador de Plasminógeno de Tipo Uroquinasa/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA